Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Colicins U and Y inhibit growth of Escherichia coli strains via recognition of conserved OmpA extracellular loop 1

J. Bosák, L. Micenková, M. Doležalová, D. Šmajs,

. 2016 ; 306 (7) : 486-494. [pub] 20160802

Language English Country Germany

Document type Journal Article

Interactions of colicins U and Y with the OmpA (Outer membrane protein A) receptor molecule were studied using site-directed mutagenesis and colicin binding assay. A systematic mutagenesis of the colicin-susceptible OmpA sequence from Escherichia coli (OmpAEC) to the colicin-resistant OmpA sequence from Serratia marcescens (OmpASM) was performed in regions corresponding to extracellular OmpA loops 1-4. Susceptibility to colicins U and Y was significantly affected by the OmpA mutation in loop 1. As with functional analysis, a decrease in binding capacity of His-tagged colicin U was found for recombinant OmpA with a mutated segment in loop 1 compared to control OmpAEC. To verify the importance of the identified amino acid residues in OmpA loop 1, we introduced loop 1 from OmpAEC into OmpASM, which resulted in the substantial increase of susceptibility to colicins U and Y. In addition, colicins U and Y were tested against a panel of 118 bacteriocin non-producing strains of four Escherichia species, including E. coli (39 strains), E. fergusonii (10 strains), E. hermannii (42 strains), and E. vulneris (27 strains). A majority (82%) of E. coli strains was susceptible to colicins U and Y. Interestingly, colicins U and Y also inhibited all of the 30 tested multidrug-resistant E. coli O25b-ST131 isolates. These findings, together with the fact that OmpA loop 1 is important for bacterial virulence and is evolutionary conserved, offer the potential of using colicins U and Y as specific anti-OmpA loop 1 directed antibacterial proteins.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013441
003      
CZ-PrNML
005      
20170426121103.0
007      
ta
008      
170413s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijmm.2016.07.002 $2 doi
035    __
$a (PubMed)27510856
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Bosák, Juraj $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic.
245    10
$a Colicins U and Y inhibit growth of Escherichia coli strains via recognition of conserved OmpA extracellular loop 1 / $c J. Bosák, L. Micenková, M. Doležalová, D. Šmajs,
520    9_
$a Interactions of colicins U and Y with the OmpA (Outer membrane protein A) receptor molecule were studied using site-directed mutagenesis and colicin binding assay. A systematic mutagenesis of the colicin-susceptible OmpA sequence from Escherichia coli (OmpAEC) to the colicin-resistant OmpA sequence from Serratia marcescens (OmpASM) was performed in regions corresponding to extracellular OmpA loops 1-4. Susceptibility to colicins U and Y was significantly affected by the OmpA mutation in loop 1. As with functional analysis, a decrease in binding capacity of His-tagged colicin U was found for recombinant OmpA with a mutated segment in loop 1 compared to control OmpAEC. To verify the importance of the identified amino acid residues in OmpA loop 1, we introduced loop 1 from OmpAEC into OmpASM, which resulted in the substantial increase of susceptibility to colicins U and Y. In addition, colicins U and Y were tested against a panel of 118 bacteriocin non-producing strains of four Escherichia species, including E. coli (39 strains), E. fergusonii (10 strains), E. hermannii (42 strains), and E. vulneris (27 strains). A majority (82%) of E. coli strains was susceptible to colicins U and Y. Interestingly, colicins U and Y also inhibited all of the 30 tested multidrug-resistant E. coli O25b-ST131 isolates. These findings, together with the fact that OmpA loop 1 is important for bacterial virulence and is evolutionary conserved, offer the potential of using colicins U and Y as specific anti-OmpA loop 1 directed antibacterial proteins.
650    _2
$a proteiny vnější bakteriální membrány $x genetika $x metabolismus $7 D001425
650    _2
$a koliciny $x metabolismus $7 D003087
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a Escherichia coli $x účinky léků $x genetika $x růst a vývoj $7 D004926
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a vazba proteinů $7 D011485
650    _2
$a Serratia marcescens $x genetika $7 D012706
655    _2
$a časopisecké články $7 D016428
700    1_
$a Micenková, Lenka $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic.
700    1_
$a Doležalová, Magda $u Department of Environment Protection Engineering, Faculty of Technology, Tomas Bata University in Zlín, T. G. Masaryk square 275, Zlín, Czech Republic.
700    1_
$a Šmajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic. Electronic address: dsmajs@med.muni.cz.
773    0_
$w MED00005699 $t International journal of medical microbiology IJMM $x 1618-0607 $g Roč. 306, č. 7 (2016), s. 486-494
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27510856 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426121422 $b ABA008
999    __
$a ok $b bmc $g 1199906 $s 974219
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 306 $c 7 $d 486-494 $e 20160802 $i 1618-0607 $m International journal of medical microbiology $n Int J Med Microbiol $x MED00005699
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...